Breyanzi 120000000 Cells (Lisocabtagene Maraleucel SUSPENSION) 120000000 CELLS

BREYANZI 120000000 CELLS is a specialized suspension used in advanced medical treatments. This product contains lisocabtagene maraleucel, a cellular therapy designed for specific conditions. Learn more about its uses and effects.

Strength

120000000 CELLS

Manufacturer / TM Owner

BRISTOL-MYERS SQUIBB CANADA

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

BREYANZI 120000000 CELLS is a cellular therapy used in the treatment of certain types of cancer. It works by using the body's own immune cells to target and destroy cancer cells. This therapy is administered intravenously and is designed for conditions that have not responded to other treatments. What is BREYANZI used for? It is primarily used in the treatment of specific cancers, providing a targeted approach to therapy.

Side Effects

The effects of BREYANZI 120000000 CELLS can vary depending on the individual. Common effects may include fatigue, fever, and other flu-like symptoms. These effects are typically managed with supportive care. It is important to discuss any concerns with a healthcare provider.

Precautions & Warnings

BREYANZI 12000000 CELLS should be handled with care and administered under the supervision of a healthcare professional. It is important to follow all safety guidelines and precautions provided by the manufacturer. Patients should be monitored closely for any adverse reactions.

Avoid Interactions

BREYANZI 120000000 CELLS may interact with other medications or treatments. It is important to inform your healthcare provider about all medications you are taking. Alcohol and certain other substances may also interact with this therapy, so it is important to discuss any potential interactions with a healthcare professional.

Frequently Asked Questions

BREYANZI is used in the treatment of certain types of cancer, providing a targeted approach to therapy.

BREYANZI is administered intravenously under the supervision of a healthcare professional.

Common effects may include fatigue, fever, and other flu-like symptoms, which are typically managed with supportive care.

Yes, BREYANZI may interact with other medications or treatments, so it is important to inform your healthcare provider about all medications you are taking.

BREYANZI should be handled with care and administered under the supervision of a healthcare professional, following all safety guidelines and precautions.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.